Meridian Wealth Management, LLC
Position in NMRA — Neumora Therapeutics, Inc.
CIK 1697300
LEXINGTON, KY
Position in NMRA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$199,680
+$45,024 QoQ
Shares Held
102,400
+18.5% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Meridian Wealth Management, LLC holds $5,624,022 across 8 Biotechnology names. NMRA ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,024 | $3,722,496 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
133,065 | $570,848 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
828 | $369,735 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
48,641 | $329,299 | |
| 5 | INSM |
INSMED Inc
|
1,529 | $250,022 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
This page
|
102,400 | $199,680 | |
| 7 | IMMP |
IMMUTEP Ltd
|
449,550 | $157,342 | |
| 8 | BYSI |
BeyondSpring Inc.
|
15,000 | $24,600 |
All Filings in NMRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $199,680 | 102,400 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $154,656 | 86,400 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $108,108 | 59,400 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||